A Study of LY3484356 in Chinese Participants With Advanced Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: LY3484356
Sponsor: Eli Lilly and Company